VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
GNWGenworth Financial, Inc.
$8.95$3.4B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

GNW logoGenworth Financial, Inc.(GNW)Earnings, Financials & Key Ratios

GNW•NYSE•Insurance & Managed Care
16.6× P/E·Price updated Jun 19, 2026
SectorFinancial ServicesIndustryLife InsuranceSub-IndustryLegacy blocks and life policy investors
AboutGenworth Financial, Inc. provides insurance products in the United States and internationally. The company operates in three segments: Enact, U.S. Life Insurance, and Runoff. The Enact segment offers mortgage insurance products primarily insuring prime-based, individually underwritten residential mortgage loans; and pool mortgage insurance products. The U.S. Life Insurance segment offers long-term care insurance products; and service traditional life insurance and fixed annuity products in the United States. The Runoff segment includes variable annuity, variable life insurance, and corporate-owned life insurance, as well as funding agreements. It distributes its products through sales force, in-house sales representatives, and digital marketing programs. The company was founded in 1871 and is headquartered in Richmond, Virginia.Show more
  • Revenue$6.37B-10.9%
  • Combined Ratio93.2%+1.7%
  • Net Income$223M-25.4%
  • Return on Equity2.32%-31.0%
  • Medical Cost Ratio75.72%-17.9%
  • Operating Margin6.8%-18.4%
  • Net Margin3.5%-16.3%
  • ROA0.25%-24.2%
  • Equity / Assets11.09%+2.1%

GNW Key Insights

Genworth Financial, Inc. (GNW) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Profitable underwriting: 93.2% combined ratio
  • ✓Strong Piotroski F-Score: 7/9
  • ✓Share count reduced 5.8% through buybacks
  • ✓Trading at only 0.4x book value

✗Weaknesses

  • ✗Weak 3Y average ROE of 2.2%

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when GNW posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

GNW Price & Volume

Genworth Financial, Inc. (GNW) stock price & volume — 10-year historical chart

Loading chart...

GNW Growth Metrics

Genworth Financial, Inc. (GNW) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-2.9%
5 Years-4.96%
3 Years-4.87%
TTM-2.93%

Profit CAGR

10 Years-
5 Years4.61%
3 Years-37.56%
TTM16.36%

EPS CAGR

10 Years-
5 Years-18.37%
3 Years-23.16%
TTM5.49%

Return on Capital

10 Years0.88%
5 Years0.82%
3 Years0.53%
Last Year0.59%

GNW Recent Earnings

Genworth Financial, Inc. (GNW) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 4/12 qtrs (33%)●Beat Revenue 2/12 qtrs (40%)
Q2 2026Latest
May 5, 2026
Metric
Actual
Est
EPS
$0.28+60.0%
$0.17
Rev
$1.8B+3.1%
$1.7B
Q1 2026
Feb 23, 2026
Metric
Actual
Est
EPS
$0.02-87.5%
$0.16
Rev
$1.8B+19.5%
$1.5B
Q4 2025
Nov 5, 2025
Metric
Actual
Est
EPS
$0.04-60.0%
$0.10
Rev
$1.9B
—
Q3 2025
Jul 30, 2025
Metric
Actual
Est
EPS
$0.16+166.7%
$0.06
Rev
$1.7B
—
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 5, 2026
$0.28vs $0.17+60.0%
$1.8Bvs $1.7B+3.1%
Q1 2026Feb 23, 2026
$0.02vs $0.16-87.5%
$1.8Bvs $1.5B+19.5%
Q4 2025Nov 5, 2025
$0.04vs $0.10-60.0%
$1.9B
Q3 2025Jul 30, 2025
$0.16vs $0.06+166.7%
$1.7B
Based on last 12 quarters of dataView full earnings history →

GNW Peer Comparison

Genworth Financial, Inc. (GNW) competitors in Legacy blocks and life policy investors — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
RDN logoRDNRadian Group Inc.Direct Competitor4.73B34.708.38-3.36%40.28%12.01%0.24
ESNT logoESNTEssent Group Ltd.Direct Competitor5.39B58.458.47-0.49%53.34%12.01%0.09
NMIH logoNMIHNMI Holdings, Inc.Direct Competitor2.85B37.487.628.39%55.07%15.8%0.16
MTG logoMTGMGIC Investment CorporationDirect Competitor5.51B26.068.300.49%59.63%14%0.13
PFSI logoPFSIPennyMac Financial Services, Inc.Direct Competitor4.3B82.388.86173.81%14.31%12.02%5.35
LNC logoLNCLincoln National CorporationProduct Competitor7.11B37.176.361.24%9.14%16.79%0.59
CNO logoCNOCNO Financial Group, Inc.Product Competitor4.76B50.8321.630.94%4.94%8.6%1.54
GL logoGLGlobe Life Inc.Product Competitor13.4B170.7612.153.82%19.36%20.64%0.44

Compare GNW vs Peers

Genworth Financial, Inc. (GNW) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs RDN

Most directly comparable listed peer for GNW.

Scale Benchmark

vs AFL

Larger-name benchmark to compare GNW against a more recognizable public peer.

Peer Set

Compare Top 5

vs RDN, ESNT, NMIH, MTG

GNW Income Statement

Genworth Financial, Inc. (GNW) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Revenue
7.51B7.89B7.71B8.21B7.6B7.4B7.37B7.14B6.37B6.87B
Revenue Growth %
-10.16%5.02%-2.33%6.57%-7.46%-2.67%-0.34%-3.09%-10.86%-2.93%
Medical Costs & Claims
7.12B7.51B6.95B7.16B6.55B6.02B7.07B6.58B4.82B4.57B
Medical Cost Ratio %
94.77%95.16%90.23%87.2%86.2%81.45%95.88%92.19%75.72%66.54%
Gross Profit
393M▲ 0%
382M▼ 2.8%
753M▲ 97.1%
1.05B▲ 39.6%
1.05B▼ 0.2%
1.37B▲ 30.8%
304M▼ 77.8%
558M▲ 83.6%
1.55B▲ 177.1%
522M▲ 0%
Gross Margin %
5.23%4.84%9.77%12.8%13.8%18.55%4.12%7.81%24.28%7.6%
Gross Profit Growth %
-39.63%-2.8%97.12%39.57%-0.19%30.79%-77.84%83.55%177.06%-
Operating Expenses
266M245M231M123M-63M7M1M-37M1.11B428M
OpEx / Revenue %
3.54%3.11%3%1.5%-0.83%0.09%0.01%-0.52%17.48%6.23%
Depreciation & Amortization
0000000093M0
Combined Ratio %
98.31%98.26%93.23%88.7%85.37%81.54%95.89%91.67%93.2%72.77%
Operating Income
127M▲ 0%
137M▲ 7.9%
522M▲ 281.0%
928M▲ 77.8%
1.11B▲ 19.8%
1.36B▲ 22.8%
303M▼ 77.8%
595M▲ 96.4%
433M▼ 27.2%
387M▲ 0%
Operating Margin %
1.69%1.74%6.77%11.3%14.63%18.46%4.11%8.33%6.8%5.63%
Operating Income Growth %
-60.31%7.87%281.02%77.78%19.83%22.75%-77.8%96.37%-27.23%-
EBITDA
393M393M752M1.12B1.27B1.47B421M710M526M466M
EBITDA Margin %
5.23%4.98%9.76%13.68%16.74%19.89%5.71%9.94%8.26%6.78%
Interest Expense
266M256M231M195M160M106M118M115M105M104M
Non-Operating Income
-266M-256M-230M-195M-160M-106M-118M-115M-105M-79M
Pretax Income
127M▲ 0%
137M▲ 7.9%
521M▲ 280.3%
928M▲ 78.1%
1.11B▲ 19.8%
1.36B▲ 22.8%
303M▼ 77.8%
595M▲ 96.4%
433M▼ 27.2%
418M▲ 0%
Pretax Margin %
1.69%1.74%6.76%11.3%14.63%18.46%4.11%8.33%6.8%6.08%
Income Tax
-406M70M139M230M248M319M104M158M84M79M
Effective Tax Rate %
-319.69%51.09%26.68%24.78%22.3%23.37%34.32%26.55%19.4%18.9%
Net Income
817M▲ 0%
119M▼ 85.4%
343M▲ 188.2%
178M▼ 48.1%
850M▲ 377.5%
916M▲ 7.8%
76M▼ 91.7%
299M▲ 293.4%
223M▼ 25.4%
249M▲ 0%
Net Margin %
10.87%1.51%4.45%2.17%11.19%12.39%1.03%4.19%3.5%3.62%
Net Income Growth %
394.95%-85.43%188.24%-48.1%377.53%7.76%-91.7%293.42%-25.42%16.36%
EPS (Diluted)
1.63▲ 0%
0.24▼ 85.3%
1.02▲ 325.0%
1.49▲ 46.1%
1.76▲ 18.1%
1.19▼ 32.4%
0.16▼ 86.6%
0.68▲ 325.0%
0.54▼ 20.6%
0.63▲ 0%
EPS Growth %
391.07%-85.28%325%46.08%18.12%-32.39%-86.55%325%-20.59%5.49%
EPS (Basic)
1.640.241.031.511.781.210.160.690.55-
Diluted Shares Outstanding
501.4M500.4M509.7M511.6M514.7M511M474.9M439.4M414M393.7M

GNW Balance Sheet

Genworth Financial, Inc. (GNW) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Assets
105.3B100.92B101.34B105.75B99.17B89.71B90.82B86.87B88.08B86.77B
Asset Growth %
0.61%-4.15%0.42%4.35%-6.22%-9.54%1.23%-4.35%1.4%-1.9%
Total Investment Assets
73.39B70.11B71.23B73.65B70.38B56.62B56.93B54.79B55.69B4M
Long-Term Investments
65.16B61.5B60.58B63.88B60.68B46.9B47.18B45.42B49.57B99.31B
Short-Term Investments
63.34B60.32B60.58B63.88B60.48B46.58B46.78B5.67B6.11B45.09B
Total Current Assets
2.88B2.18B00000026.59B47.22B
Cash & Equivalents
2.88B2.18B3.34B2.56B1.57B1.8B2.21B2.05B2.04B2.12B
Receivables
0017.1B16.82B16.81B19B19.02B17.66B18.44B54.58B
Other Current Assets
00-81.02B-83.26B-78.86B-67.38B-68.02B-25.38B00
Goodwill & Intangibles
301M347M201M157M143M203M198M197M1.78B5.66B
Goodwill
15M13M5M000000199M
Intangible Assets
286M334M196M157M143M203M198M01.78B0
PP&E (Net)
-504M-736M00000000
Other Assets
-25.56B-22.77B-60.78B-64.04B-60.82B-47.1B-47.38B-45.61B8.34B0
Total Liabilities
89.97B86.73B86.71B89.93B82.91B81.33B82.48B77.44B78.32B76.93B
Total Debt
4.57B4.34B3.98B3.4B1.9B1.61B1.58B1.52B1.51B0
Net Debt
1.7B2.16B644M842M328M-188M-631M-530M-523M-2.12B
Long-Term Debt
4.57B4.02B3.59B3.4B1.9B1.61B1.58B1.52B1.51B0
Short-Term Debt
597M0397M0000000
Total Current Liabilities
87.31B84.45B00000013.94B0
Accounts Payable
0000000000
Deferred Revenue
0000000092M0
Other Current Liabilities
-597M0-397M0000013.84B0
Deferred Taxes
1000K1000K00000000
Other Liabilities
85.37B0-3.58B-3.38B-1.88B-1.6B-1.58B-1.52B62.87B76.93B
Total Equity
15.33B▲ 0%
14.19B▼ 7.4%
14.63B▲ 3.1%
15.82B▲ 8.1%
16.27B▲ 2.8%
8.39B▼ 48.4%
8.34B▼ 0.6%
9.43B▲ 13.1%
9.77B▲ 3.6%
9.84B▲ 0%
Equity Growth %
5.95%-7.43%3.12%8.12%2.82%-48.44%-0.61%13.15%3.56%15.89%
Shareholders Equity
13.42B12.45B14.19B15.32B15.51B7.63B7.48B8.49B8.75B8.81B
Minority Interest
1.91B1.74B447M502M756M755M855M937M1.02B1.03B
Retained Earnings
1.11B1.12B1.46B1.58B2.49B1.14B1.21B1.51B1.68B1.73B
Common Stock
1M1M1M1M1M1M1M1M1M1M
Accumulated OCI
3.03B2.04B3.43B4.42B3.86B-2.61B-2.56B-1.64B-1.32B-1.22B
Return on Equity (ROE)
5.48%0.81%2.38%1.17%5.3%7.43%0.91%3.37%2.32%2.54%
Return on Assets (ROA)
0.78%0.12%0.34%0.17%0.83%0.97%0.08%0.34%0.25%0.28%
Equity / Assets
14.56%14.06%14.44%14.96%16.4%9.35%9.18%10.86%11.09%11.34%
Debt / Equity
0.30x0.31x0.27x0.22x0.12x0.19x0.19x0.16x0.15x0.00x
Book Value per Share
30.5728.3628.7130.9231.6016.4117.5521.4623.5925.00
Tangible BV per Share
29.9727.6628.3130.6231.3316.0117.1321.4619.2824.49

GNW Cash Flow Statement

Genworth Financial, Inc. (GNW) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
2.55B1.63B2.08B1.96B437M1.05B597M88M327M384M
Operating CF Growth %
37.91%-36.06%27.31%-5.72%-77.7%140.05%-43.09%-85.26%271.59%748.14%
Operating CF / Revenue %
33.99%20.7%26.98%23.87%5.75%14.18%8.1%1.23%5.14%5.59%
Net Income
936M297M519M761M864M1.05B76M4M350M249M
Depreciation & Amortization
288M269M557M-570M0040M130M93M0
Stock-Based Compensation
42M37M27M39M40M37M49M51M58M62M
Deferred Taxes
-368M5M139M268M275M315M48M-103M-55M-34M
Other Non-Cash Items
-363M-883M-699M-646M-1.76B-884M-933M-618M-925M-740M
Working Capital Changes
2.02B1.91B1.54B2.11B1.01B535M1.32B624M806M761M
Cash from Investing
-759M-622M1.3B-1.15B896M733M1.26B861M518M527M
Capital Expenditures
000267M000000
Acquisitions
-5M01.4B-267M-242M-460M-384M00-163M
Purchase of Investments
-9.59B-10.71B-7.29B-9.84B-5.22B-4.04B-3.23B00-3.03B
Sale/Maturity of Investments
8.99B10.35B7.32B8.29B6.45B5.39B4.66B003.8B
Other Investing
-157M-266M-128M387M-99M-158M215M861M518M-77M
Cash from Financing
-1.77B-1.62B-2.22B-1.51B-2.42B-1.55B-1.44B-1.11B-857M-682M
Dividends Paid
-107M-97M-87M0000-21M0-6M
Share Repurchases
-33M0-22M00-64M-296M-189M-319M-293M
Stock Issued
0022M0529M00000
Debt Issuance (Net)
-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K
Other Financing
-1.73B-1.42B-1.68B-1.44B-1.41B-1.19B-1.11B-831M-531M-443M
Net Change in Cash
91M▲ 0%
-698M▼ 867.0%
1.16B▲ 266.8%
-685M▼ 158.8%
-1.08B▼ 58.4%
228M▲ 121.0%
416M▲ 82.5%
-167M▼ 140.1%
-12M▲ 92.8%
229M▲ 0%
Exchange Rate Effect
64M-88M1M15M1M01M-1M00
Cash at Beginning
2.78B2.88B2.18B3.34B2.66B1.57B1.8B2.21B2.05B2.04B
Cash at End
2.88B2.18B3.34B2.66B1.57B1.8B2.21B2.05B2.04B2.12B
Free Cash Flow
2.55B▲ 0%
1.63B▼ 36.1%
2.08B▲ 27.3%
2.23B▲ 7.1%
437M▼ 80.4%
1.05B▲ 140.0%
597M▼ 43.1%
88M▼ 85.3%
327M▲ 271.6%
384M▲ 0%
FCF Growth %
37.91%-36.06%27.31%7.12%-80.38%140.05%-43.09%-85.26%271.59%67.69%
FCF Margin %
33.99%20.7%26.98%27.12%5.75%14.18%8.1%1.23%5.14%5.59%
FCF per Share
5.093.264.084.350.852.051.260.20.790.98

GNW Key Ratios

Genworth Financial, Inc. (GNW) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Combined Ratio
98.31%98.26%93.23%88.7%85.37%81.54%95.89%91.67%93.2%72.77%
Medical Cost Ratio
94.77%95.16%90.23%87.2%86.2%81.45%95.88%92.19%75.72%66.54%
Return on Equity (ROE)
5.48%0.81%2.38%1.17%5.3%7.43%0.91%3.37%2.32%2.54%
Return on Assets (ROA)
0.78%0.12%0.34%0.17%0.83%0.97%0.08%0.34%0.25%0.28%
Equity / Assets
14.56%14.06%14.44%14.96%16.4%9.35%9.18%10.86%11.09%11.34%
Book Value / Share
30.5728.3628.7130.9231.616.4117.5521.4623.5925
Debt / Equity
0.30x0.31x0.27x0.22x0.12x0.19x0.19x0.16x0.15x0.00x
Revenue Growth
-10.16%5.02%-2.33%6.57%-7.46%-2.67%-0.34%-3.09%-10.86%-2.93%
Related:GNW Dividend History·GNW Revenue History·GNW Price History·GNW P/E History·GNW Financial Ratios·GNW Institutional Holders

GNW SEC Filings & Documents

Genworth Financial, Inc. (GNW) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 5, 2026·SEC

Material company update

Feb 23, 2026·SEC

Material company update

Feb 3, 2026·SEC

10-K Annual Reports

3
FY 2026

Feb 27, 2026·SEC

FY 2025

Feb 28, 2025·SEC

FY 2024

Feb 29, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 6, 2026·SEC

FY 2025

Nov 6, 2025·SEC

FY 2025

Jul 31, 2025·SEC

GNW Frequently Asked Questions

Genworth Financial, Inc. (GNW) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Genworth Financial, Inc. (GNW) saw revenue decline by 10.9% over the past year.

Yes, Genworth Financial, Inc. (GNW) is profitable, generating $249.0M in net income for fiscal year 2025 (3.5% net margin).

Dividend & Returns

Genworth Financial, Inc. (GNW) has a return on equity (ROE) of 2.3%. This is below average, suggesting room for improvement.

Industry Metrics

Genworth Financial, Inc. (GNW) has a combined ratio of 93.2%. A ratio below 100% indicates underwriting profitability.

What if you invested $1,000 in GNW back in 2002?

Total return calculator · dividends reinvested · 24+ years of data

See returns →

How much would $100/month in GNW be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →